Yıl: 2020 Cilt: 48 Sayı: 3 Sayfa Aralığı: 263 - 269 Metin Dili: İngilizce DOI: doi: 10.5543/tkda.2019.58665 İndeks Tarihi: 15-11-2020

Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease

Öz:
Objective: Chronic obstructive pulmonary disease (COPD) is associated with atrial fibrillation (AF) and reduced forced expiratory volume (FEV1) is an independent predictor for new onset AF. The aims of this study were (1) to analyze the atrial electromechanical delay (AEMD) and P wave dispersion which are two predictors of AF development in patients with COPD and without any cardiovascular disease, and (2) to assess the relationship of those with pulmonary functions as quantified by FEV1 measurements. Methods: The study included 41 patients with COPD (33 male; mean age: 51 years) and 32 healthy controls. P wave dispersion was calculated as the difference between the maximum and minimum P wave duration in a 12-lead surface electrocardiography (ECG) recording. AEMD, defined as the time interval from the P wave onset on the ECG to the initiation of the late diastolic (Am) wave using a tissue Doppler examination, was measured from the lateral mitral annulus (LAEMD), septal annulus (SAEMD), and tricuspid lateral annulus (TAEMD). Results: P wave dispersion was significantly longer in the COPD group than those in the controls (76±19 ms vs. 45±10 ms; p<0.001). All of the AEMD measurements demonstrated significant prolongation in patients with COPD(LAEMD: 74±9 ms vs. 64±11 ms; SAEMD: 66±10 ms vs. 57±12 ms; and TAEMD: 65±9 ms vs. 46±7 ms; p<0.001 for all). The only correlation with FEV1 was observed in the TAEMD values of the COPD group (rs: -401; p<0.009). Conclusion: Both P wave dispersion and AEMD parameters were significantly longer in COPD patients without any established structural or functional cardiac abnormalities, indicating an increased tendency for AF development, beginning from the initial stages of the disease.
Anahtar Kelime:

Kronik obstrüktif akciğer hastalarında atriyal elektromekanik gecikmenin ve P dalga dispersiyonun değerlendirilmesi

Öz:
Amaç: Kronik obstrüktif akciğer hastalığı (KOAH) ile atriyal fibrilasyonu (AF) ilişkidir ve azalmış birinci saniye zorlu ekspiratuvar volümü (ZEV1) yeni başlangıçlı AF için bağımsız bir etkendir. Bu çalışmanın amacı bilinen kardiyovasküler hastalığı olmayan KOAH hastalarında 2 AF öngördürücüsünün; P dalga dispersiyonunun ve atriyal elektromekanik gecikmenin (AEMG) değerlendirilmesidir ve bunların ZEV1 ile nicelenen solunum fonksiyonlarıyla ilişkisinin değerlendirilmesidir. Yöntemler: Çalışmaya 41 KOAH hastası (33 erkek, ortalama yaş 51) ile 32 sağlıklı birey katıldı. P dalga dispersiyonu elektrokardiyogram üzerinde 12 derivasyon arasında maksimum ve minimum P dalga süreleri arasındaki fark alınarak hesaplandı. P dalgasının başlangıcından doku Doppler görüntülemesi ile saptanan geç diyastolik dalgasına (Am dalgası) kadar olan süre olarak tanımlanan AEMG ölçümü; lateral mitral anulusdan (LMAEMG), septal (SMAEMG) ve lateral triküspit anulusdan (LTAEMG) yapıldı. Bulgular: P dalga dispersiyonu KOAH grubunda kontrol grubundan anlamlı olarak uzundu (76±19 ve 45±10 ms, p<0.001). Tüm AEMG ölçümleri hasta grubunda anlamlı uzama gösterdi (LMAEMG: 74±9 ve 64±11 ms, SMAEMG: 66±10 ve 57±12 ms ile LTAEMG: 65±9 ve 46±7 ms; hepsi için p<0.001). Ayrıca, FEV1 ile yalnız LTAEMG arasında ilişki gözlendi (rs: -401, p <0.009). Sonuç: Hem P dalga dispersiyonu hem atriyal elektromekanik gecikme parametreleri hastalığın erken dönemlerinden başlamak üzere yapısal ve fonksiyonel kardiyak hastalığı olmayan KOAH hastalarında AF’ye artmış eğilimin göstergesi olarak anlamlı uzundu.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5:020415.
  • 2. Goudis CA. Chronic obstructive pulmonary disease and atrial f ibrillation: An unknown relationship. J Cardiol 2017;69:699705.
  • 3. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003;21:1012–6.
  • 4. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial f ibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50:e1–e88.
  • 5. Acar G, Kahraman H, Akkoyun M, Kilinc M, Zencir C, Yusufoglu E, et al. Evaluation of Atrial Electromechanical Delay and Its Relationship to Inflammation and Oxidative Stress in Patients with Chronic Obstructive Pulmonary Disease. Echocardiography 2014;31:579–85.
  • 6. Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis 2016;5:2048004016639443.
  • 7. Merckx KL, De Vos CB, Palmans A, Habets J, Cheriex EC, Crijns HJ, al. Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation. J Am Soc Echocardiogr 2005;18:940–4.
  • 8. Yoshizawa T, Niwano S, Niwano H, Igarashi T, Fujiishi T, Ishizue N, et al. Prediction of new onset atrial fibrillation through P wave analysis in 12 lead ECG. Int Heart J 2014;55:422–7.
  • 9. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–70.
  • 10. Leong P, Macdonald MI, Ko BS, Bardin PG. Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge. Med J Aust 2019;210:417–23.
  • 11. Grymonprez M, Vakaet V, Kavousi M, Stricker BH, Ikram MA, Heeringa J, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol 2019;276:118–24.
  • 12. Dilaveris PE, Gialafos JE. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2001;6:159–65.
  • 13. Tükek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, et al. Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 2002;7:222–7.
  • 14. Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018;25:1437–51.
  • 15. Akturk E, Yağmur J, Açıkgöz N, Ermiş N, Cansel M, Karakuş Y, et al. Assessment of atrial conduction time by tissue Doppler echocardiography and P-wave dispersion in smokers. J Interv Card Electrophysiol 2012;34:247–53.
  • 16. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131:1557–66.
  • 17. Goette A, Lendeckel U, Kuchenbecker A, Bukowska A, Peters B, Klein HU, et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart 2007;93:1056–63.
  • 18. Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, et al. Smoking and incidence of atrial f ibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study Heart Rhythm 2011;8:1160–6.
  • 19. Ozer N, Yavuz B, Can I, Atalar E, Aksöyek S, Ovünç K, et al. Doppler tissue evaluation of intra-atrial and interatrial electromechanical delay and comparison with P-wave dispersion in patients with mitral stenosis. J Am Soc Echocardiogr 2005;18:945–8.
  • 20. Omi W, Nagai H, Takamura M, Okura S, Okajima M, Furusho H, et al. Doppler tissue analysis of atrial electromechanical coupling in paroxysmal atrial fibrillation. J Am Soc Echocardiogr 2005;18:39–44.
  • 21. Van Beeumen K, Duytschaever M, Tavernier R, Van de Veire N, De Sutter J. Intra- and interatrial asynchrony in patients with heart failure. Am J Cardiol 2007;99:79–83.
  • 22. Bilgin M, Yıldız BS, Tülüce K, Gül İ, Alkan MB, Sayın A, et al. Evaluating functional capacity, and mortality effects in the presence of atrial electromechanical conduction delay in patients with systolic heart failure. Anatol J Cardiol 2016;16:579–86.
  • 23. Acar G, Akcay A, Sokmen A, Ozkaya M, Guler E, Sokmen G, et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr 2009;22:732–8.
  • 24. Demir K, Avci A, Kaya Z, Marakoglu K, Ceylan E, Yilmaz A, et al. Assessment of atrial electromechanical delay and Pwave dispersion in patients with type 2 diabetes mellitus. J Cardiol 2016;67:378–83.
  • 25. Akyel A, Oksüz F, Karadeniz M, Yarlıoğlueş M, Ergün G, Cankurt T, et al. Atrial electromechanical delay in type 2 diabetes mellitus. Wien Klin Wochenschr 2014;126:101–5.
  • 26. Bulut M, Evlice M, Celik M, Eren H, Savluk ÖF, Acar RD, et al. Atrial electromechanical delay in patients undergoing heart transplantation. J Arrhythm 2017;33:122–6.
  • 27. Caglar IM, Dasli T, Turhan Caglar FN, Teber MK, Ugurlucan M, Ozmen G. Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 2012;101:599–606.
  • 28. Ogi H, Nakano Y, Niida S, Dote K, Hirai Y, Suenari K, et al. Is structural remodeling of fibrillated atria the consequence of tissue hypoxia? Circ J 2010;74:1815–21.
  • 29. Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 2010;7:1263–70.
  • 30. Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest 2013;144:266–73.
  • 31. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 2011;8:514–22.
  • 32. Hodgkinson JA, Taylor CJ, Hobbs FD. Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study. Br J Gen Pract 2011;61:e353–61.
  • 33. Matarese A, Sardu C, Shu J, Santulli G. Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms. Int J Cardiol 2019;276:149–51.
  • 34. Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace 2014;16:182–8.
APA CİMCİ M, BÖREKÇİ Ş, AVCI B, HYSİ E, ÖNGEN H, KARADAĞ B, ÖZDEN TOK Ö, Durmaz E, KARPUZ H (2020). Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. , 263 - 269. doi: 10.5543/tkda.2019.58665
Chicago CİMCİ Murat,BÖREKÇİ Şermin,AVCI Burcak KILIÇKIRAN,HYSİ Ergi,ÖNGEN Hürrem Gül,KARADAĞ Bilgehan,ÖZDEN TOK Özge,Durmaz Eser,KARPUZ Hakan Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. (2020): 263 - 269. doi: 10.5543/tkda.2019.58665
MLA CİMCİ Murat,BÖREKÇİ Şermin,AVCI Burcak KILIÇKIRAN,HYSİ Ergi,ÖNGEN Hürrem Gül,KARADAĞ Bilgehan,ÖZDEN TOK Özge,Durmaz Eser,KARPUZ Hakan Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. , 2020, ss.263 - 269. doi: 10.5543/tkda.2019.58665
AMA CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. . 2020; 263 - 269. doi: 10.5543/tkda.2019.58665
Vancouver CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. . 2020; 263 - 269. doi: 10.5543/tkda.2019.58665
IEEE CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H "Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease." , ss.263 - 269, 2020. doi: 10.5543/tkda.2019.58665
ISNAD CİMCİ, Murat vd. "Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease". (2020), 263-269. https://doi.org/doi: 10.5543/tkda.2019.58665
APA CİMCİ M, BÖREKÇİ Ş, AVCI B, HYSİ E, ÖNGEN H, KARADAĞ B, ÖZDEN TOK Ö, Durmaz E, KARPUZ H (2020). Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi, 48(3), 263 - 269. doi: 10.5543/tkda.2019.58665
Chicago CİMCİ Murat,BÖREKÇİ Şermin,AVCI Burcak KILIÇKIRAN,HYSİ Ergi,ÖNGEN Hürrem Gül,KARADAĞ Bilgehan,ÖZDEN TOK Özge,Durmaz Eser,KARPUZ Hakan Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi 48, no.3 (2020): 263 - 269. doi: 10.5543/tkda.2019.58665
MLA CİMCİ Murat,BÖREKÇİ Şermin,AVCI Burcak KILIÇKIRAN,HYSİ Ergi,ÖNGEN Hürrem Gül,KARADAĞ Bilgehan,ÖZDEN TOK Özge,Durmaz Eser,KARPUZ Hakan Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi, vol.48, no.3, 2020, ss.263 - 269. doi: 10.5543/tkda.2019.58665
AMA CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi. 2020; 48(3): 263 - 269. doi: 10.5543/tkda.2019.58665
Vancouver CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi. 2020; 48(3): 263 - 269. doi: 10.5543/tkda.2019.58665
IEEE CİMCİ M,BÖREKÇİ Ş,AVCI B,HYSİ E,ÖNGEN H,KARADAĞ B,ÖZDEN TOK Ö,Durmaz E,KARPUZ H "Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease." Türk Kardiyoloji Derneği Arşivi, 48, ss.263 - 269, 2020. doi: 10.5543/tkda.2019.58665
ISNAD CİMCİ, Murat vd. "Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease". Türk Kardiyoloji Derneği Arşivi 48/3 (2020), 263-269. https://doi.org/doi: 10.5543/tkda.2019.58665